Sepracor To Increase Lunesta Promotional Spend After Pfizer Drops Indiplon
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor plans to increase DTC, professional marketing programs to make up for the absence of Pfizer's initiatives to grow the sleep aid market.
You may also be interested in...
Sepracor Sees Sweet Dreams For Lunesta Despite Generic Ambien Next Year
Firm says formulary placement of the sleep aid will help mitigate Rx erosion following the launch of generic Ambien.
Sepracor Sees Sweet Dreams For Lunesta Despite Generic Ambien Next Year
Firm says formulary placement of the sleep aid will help mitigate Rx erosion following the launch of generic Ambien.
Rozerem DTC Ads Highlight Low Abuse Potential Of Sleep Aid
Takeda launches Rozerem TV spots promoting sweet dreams with a humorous approach.